Grachev M A, Kolocheva T I, Lukhtanov E A, Mustaev A A
Eur J Biochem. 1987 Feb 16;163(1):113-21. doi: 10.1111/j.1432-1033.1987.tb10743.x.
RNA polymerase was treated in the presence of promoter-containing templates with 16 affinity reagents, derivatives on NMPs, NDPs and NTPs with reactive substituents at the terminal phosphate. This treatment was followed by addition of a pyrimidine [alpha-32P]NTP. Due to 'catalytic competence' of some of the residues of the affinity reagents bound covalently near the active center at the first stage, active-center-catalyzed synthesis of a phosphodiester bond occurred, and radioactive residues with the general formula -pNpN (where p = radioactive phosphate) appeared covalently attached to the enzyme. Such affinity labelling was super-selective because affinity reagent residues bound outside the active center were not elongated and thus remained non-radioactive. Labelling took place only when the combination of the reagent and [alpha-32P]NTP corresponded to the sequence of nucleotides of the promoter. With reagents having short 'arms', only the beta subunit was labelled; the targets were His and/or Lys residues. With reagents having longer 'arms', the sigma subunit was also labelled.
在含有启动子的模板存在下,用16种亲和试剂处理RNA聚合酶,这些试剂是在NMP、NDP和NTP的末端磷酸上带有反应性取代基的衍生物。处理后加入嘧啶[α-32P]NTP。由于在第一阶段一些亲和试剂的残基共价结合在活性中心附近具有“催化活性”,活性中心催化形成了磷酸二酯键,并且通式为-pNpN(其中p =放射性磷酸)的放射性残基共价连接到了酶上。这种亲和标记具有超选择性,因为结合在活性中心之外的亲和试剂残基不会被延长,因此仍然是非放射性的。只有当试剂和[α-32P]NTP的组合与启动子的核苷酸序列相对应时才会发生标记。对于具有短“臂”的试剂,只有β亚基被标记;靶标是His和/或Lys残基。对于具有长“臂”的试剂,σ亚基也会被标记。